Find patient assistance
Answer a few simple questions to find out which patient assistance option might be right for your patient.
Patient Assistance Tool
Find the right assistance option
- Is your patient insured?
- Does the patient’s insurance cover their OCALIVA® (obeticholic acid)?
- Does your patient have commercial insurance?
What does this mean?Commercial insurance is an insurance plan from a private health insurance company. This can be insurance from an employer, purchased directly from a health insurance company or a plan purchased from a Health Insurance Marketplace (e.g., HealthCare.gov). Medicare and Medicaid are not considered commercial insurance.
- Is your patient having issues with their out‑of‑pocket costs?
- Is the patient using the Intercept medication for an FDA‑approved indication?
- Start Over Update Response
Your patient may be eligible for financial support programs based on your coverage
Interconnect may be able to provide information on Medicare/Medicaid financial support options from independent charitable foundation programs. Call 1-844-622-4278 to learn more.
Interconnect may be able to help your patient find potential solutions for out‑of‑pocket costs. Please call 1-844-622-4278.
Access is our top priority
-
Financial assistance
Help identifying and evaluating the potential options based on your patient’s insurance plan and eligibility.a
-
Limited Drug Program
Quick Start Program: For NEW patients who have a recent denial or treatment delay.b
Interim Access Program: For EXISTING patients who have a recent denial or treatment delay.b -
No insurance or underinsured for an Intercept therapy
Qualified patients may be provided with access to Intercept treatment at no cost under the Intercept Patient Assistance Program.
Enroll Your Patients in Interconnect Now
aCertain offers not valid for patients enrolled in Medicare, Medicaid, or other federal or state healthcare programs. For program terms, conditions, and eligibility criteria click here.
bFor eligible commercial and government-insured patients.